Andre Watson is Founder, Chairman, and CEO of Ligandal, an industry pioneer in precision genetic medicine. Andre has a background in biomedical engineering and is using his knowledge of nanomaterials to develop next-generation technologies for personalized gene therapy with the ultimate goal of curing chronic illnesses and rare diseases, revolutionizing pandemic defense strategies, and increasing longevity for all. Ligandal’s expertise is grounded in an innovative delivery system similar to a molecular GPS that scales AI, computational biology, and machine learning to target specific cells for the precise delivery of gene-editing tools such as CRISPR and TALEN. Andre is currently working to build a better future for mankind by perfecting regenerative medicine and enabling equal access to quality healthcare, setting a new standard for 21st century medicine.